257
Neurocrine Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
339
FY23:
390
FY24:
595
FY25:
783
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−177
FY23:
−467
FY24:
−127
FY25:
−264
Change from FY21 to FY25
millions USD
FY21:
27.4
FY22:
−234
FY23:
65.3
FY24:
−487
FY25:
−38.3
millions USD
FY21:
154
FY22:
−73.3
FY23:
−11.6
FY24:
−18.1
FY25:
480
(positive)
Change from FY21 to FY25
millions USD
FY21:
233
FY22:
323
FY23:
362
FY24:
557
FY25:
749
All amounts in millions USD